László Gulácsi
Names
| first: |
László |
| last: |
Gulácsi |
Identifer
Contact
Affiliations
-
Budapesti Corvinus Egyetem
/ Közgazdaságtudományi Kar
/ Egészségügyi Közgazdaságtan Tanszék
Research profile
author of:
- Comparing cost-sharing practices for pharmaceuticals and health care services among four central European countries (RePEc:aka:soceco:v:34:y:2012:i:2:p:221-240)
by Petra Baji & Imre Boncz & György Jenei & László Gulácsi - Preferences of Hungarian consumers for quality, access and price attributes of health care services — result of a discrete choice experiment (RePEc:aka:soceco:v:34:y:2012:i:2:p:293-311)
by Petra Baji & Milena Pavlova & László Gulácsi & Wim Groot - User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders (RePEc:eee:hepoli:v:102:y:2011:i:2:p:255-262)
by Baji, Petra & Pavlova, Milena & Gulácsi, LászlÓ & Groot, Wim - Quality management and patient safety: Survey results from 102 Hungarian hospitals (RePEc:eee:hepoli:v:90:y:2009:i:2-3:p:175-180)
by Makai, Peter & Klazinga, Niek & Wagner, Cordula & Boncz, Imre & Gulacsi, Lászlo - Verseny az egészségügyben. Egyesült államokbeli és nyugat-európai példák
[Competition in health care. US and West European examples] (RePEc:ksa:szemle:919)
by Gulácsi, László & Kovács, Erzsébet & Oesterle, August & Boncz, Imre - The disease burden of colorectal cancer in Hungary (RePEc:spr:eujhec:v:10:y:2010:i:1:p:35-40)
by Imre Boncz & Valentin Brodszky & Márta Péntek & István Ágoston & Zsolt Nagy & Krisztián Kárpáti & Ildikó Kriszbacher & Péter Fuszek & László Gulácsi - Future challenges for health economics and health technology assessment of biological drugs (RePEc:spr:eujhec:v:11:y:2010:i:3:p:235-238)
by László Gulácsi - Health economics and health technology assessment in Central and Eastern Europe: a dose of reality (RePEc:spr:eujhec:v:13:y:2012:i:5:p:525-531)
by L. Gulácsi & E. Orlewska & M. Péntek - Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries (RePEc:spr:eujhec:v:15:y:2014:i:1:p:1-4)
by László Gulácsi - Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres (RePEc:spr:eujhec:v:15:y:2014:i:1:p:101-109)
by Orsolya Balogh & Valentin Brodszky & László Gulácsi & Emese Herédi & Krisztina Herszényi & Hajnalka Jókai & Sarolta Kárpáti & Petra Baji & Éva Remenyik & Andrea Szegedi & Péter Holló - Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary (RePEc:spr:eujhec:v:15:y:2014:i:1:p:111-119)
by Emese Herédi & Fanni Rencz & Orsolya Balogh & László Gulácsi & Krisztina Herszényi & Péter Holló & Hajnalka Jókai & Sarolta Kárpáti & Márta Péntek & Éva Remenyik & Andrea Szegedi & Valentin Brodszky - Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics (RePEc:spr:eujhec:v:15:y:2014:i:1:p:121-128)
by Mandel Michael & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos - Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics (RePEc:spr:eujhec:v:15:y:2014:i:1:p:129-129)
by Michael Mandel & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos - Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria (RePEc:spr:eujhec:v:15:y:2014:i:1:p:13-25)
by László Gulácsi & Alexandru Rotar & Maciej Niewada & Olga Löblová & Fanni Rencz & Guenka Petrova & Imre Boncz & Niek Klazinga - Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries (RePEc:spr:eujhec:v:15:y:2014:i:1:p:27-34)
by László Gulácsi & Fanni Rencz & Márta Péntek & Valentin Brodszky & Ruth Lopert & Noémi Hevér & Petra Baji - Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries (RePEc:spr:eujhec:v:15:y:2014:i:1:p:35-43)
by Márta Péntek & Gyula Poór & Piotr Wiland & Martina Olejárová & Marek Brzosko & Catalin Codreanu & Nóra Brodszky & László Gulácsi - Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis (RePEc:spr:eujhec:v:15:y:2014:i:1:p:45-52)
by Petra Baji & Márta Péntek & Sándor Szántó & Pál Géher & László Gulácsi & Orsolya Balogh & Valentin Brodszky - Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison (RePEc:spr:eujhec:v:15:y:2014:i:1:p:53-64)
by Petra Baji & Márta Péntek & László Czirják & Zoltán Szekanecz & György Nagy & László Gulácsi & Valentin Brodszky - Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective (RePEc:spr:eujhec:v:15:y:2014:i:1:p:73-82)
by Márta Péntek & Bernadette Rojkovich & László Czirják & Pál Géher & Péter Keszthelyi & Attila Kovács & László Kovács & Zita Szabó & Zoltán Szekanecz & László Tamási & Ágnes Tóth & Ilona Ujfalussy & Noé - Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists (RePEc:spr:eujhec:v:15:y:2014:i:1:p:83-92)
by Márta Péntek & László Gulácsi & Bernadette Rojkovich & Valentin Brodszky & Job Exel & Werner Brouwer - HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain (RePEc:spr:eujhec:v:15:y:2014:i:7:p:675-680)
by L. Gulácsi & M. Péntek - The link between past informal payments and willingness of the Hungarian population to pay formal fees for health care services: results from a contingent valuation study (RePEc:spr:eujhec:v:15:y:2014:i:8:p:853-867)
by Petra Baji & Milena Pavlova & László Gulácsi & Miklós Farkas & Wim Groot - The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience (RePEc:spr:eujhec:v:8:y:2007:i:2:p:83-88)
by László Gulácsi